Skip to main content

Versant Capital Management, Inc

Position in NBIX — Neurocrine Biosciences Inc

CIK 1735057 PHOENIX, AZ

Position in NBIX

as of Jun 30, 2026 · filed Jul 2, 2026
Position Value
$124,213
+$50,044 QoQ
Shares Held
737
+30.9% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#61
of 84 holders
Holding Since
Jun 2021
19 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in NBIX Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

Versant Capital Management, Inc holds $2,428,042 across 29 Drug Manufacturers - Specialty & Generic names. NBIX ranks #6 (5.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
6 NBIX
Neurocrine Biosciences Inc
This page
737 $124,213

All Filings in NBIX

Export CSV
19 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $124,213 737
2026-03-31 $74,169 563
2025-12-31 $73,893 521
2025-09-30 $72,716 518
2025-06-30 $64,981 517
2025-03-31 $45,235 409
2024-12-31 $11,056 81
2024-09-30 $4,839 42
2024-06-30 $7,709 56
2024-03-31 $965 7
2023-12-31 $922 7
2023-09-30 $450 4
2023-06-30 $848 9
2023-03-31 $404 4
2022-12-31 $1,313 11
2022-09-30 $1,168 11
2022-06-30 $1,072 11
2022-03-31 $1,031 11
2021-06-30 $291 3